Perspectives in systems nephrology
- PMID: 34027630
- PMCID: PMC8523456
- DOI: 10.1007/s00441-021-03470-3
Perspectives in systems nephrology
Abstract
Chronic kidney diseases (CKD) are a major health problem affecting approximately 10% of the world's population and posing increasing challenges to the healthcare system. While CKD encompasses a broad spectrum of pathological processes and diverse etiologies, the classification of kidney disease is currently based on clinical findings or histopathological categorizations. This descriptive classification is agnostic towards the underlying disease mechanisms and has limited progress towards the ability to predict disease prognosis and treatment responses. To gain better insight into the complex and heterogeneous disease pathophysiology of CKD, a systems biology approach can be transformative. Rather than examining one factor or pathway at a time, as in the reductionist approach, with this strategy a broad spectrum of information is integrated, including comprehensive multi-omics data, clinical phenotypic information, and clinicopathological parameters. In recent years, rapid advances in mathematical, statistical, computational, and artificial intelligence methods enable the mapping of diverse big data sets. This holistic approach aims to identify the molecular basis of CKD subtypes as well as individual determinants of disease manifestation in a given patient. The emerging mechanism-based patient stratification and disease classification will lead to improved prognostic and predictive diagnostics and the discovery of novel molecular disease-specific therapies.
Keywords: Chronic kidney diseases; Precision medicine; System nephrology.
© 2021. The Author(s).
Conflict of interest statement
Dr. Kretzler reports grants from NIH, non-financial support from University of Michigan, during the conduct of the study; grants from JDRF, Astra-Zeneca, NovoNordisk, Eli Lilly, Gilead, Goldfinch Bio, Merck, Chan Zuckerberg Initiative, Janssen, Boehringer-Ingelheim, Moderna, Chinook, amfAR, Angion, RenalytixAI, Retrophin, European Union Innovative Medicine Initiative, and Certa outside the submitted work. In addition, Dr. Kretzler has a patent PCT/EP2014/073413 “Biomarkers and methods for progression prediction for chronic kidney disease” licensed.
Figures
Similar articles
-
Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii81-8. doi: 10.1093/ndt/gfs270. Epub 2012 Jun 25. Nephrol Dial Transplant. 2012. PMID: 22734108
-
How Omics Data Can Be Used in Nephrology.Am J Kidney Dis. 2018 Jul;72(1):129-135. doi: 10.1053/j.ajkd.2017.12.008. Epub 2018 Feb 23. Am J Kidney Dis. 2018. PMID: 29478865 Free PMC article. Review.
-
Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care.PLoS One. 2015 May 20;10(5):e0127071. doi: 10.1371/journal.pone.0127071. eCollection 2015. PLoS One. 2015. PMID: 25992629 Free PMC article.
-
Application of systems biology to the study of chronic kidney disease.Chin Med J (Engl). 2012 Jul;125(14):2603-9. Chin Med J (Engl). 2012. PMID: 22882947
-
Integrated genomics and metabolomics in nephrology.Nephrol Dial Transplant. 2014 Aug;29(8):1467-74. doi: 10.1093/ndt/gft492. Epub 2013 Dec 22. Nephrol Dial Transplant. 2014. PMID: 24366899 Review.
Cited by
-
Immune-mediated glomerular diseases: new basic concepts and clinical implications.Cell Tissue Res. 2021 Aug;385(2):277-279. doi: 10.1007/s00441-021-03509-5. Epub 2021 Aug 31. Cell Tissue Res. 2021. PMID: 34463820 Free PMC article. No abstract available.
-
Integration of artificial intelligence and multi-omics in kidney diseases.Fundam Res. 2022 Mar 16;3(1):126-148. doi: 10.1016/j.fmre.2022.01.037. eCollection 2023 Jan. Fundam Res. 2022. PMID: 38933564 Free PMC article. Review.
-
[Long-term physical and psychological consequences of chronic kidney disease].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Apr;65(4):488-497. doi: 10.1007/s00103-022-03515-0. Epub 2022 Mar 21. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022. PMID: 35312814 Free PMC article. Review. German.
-
Unveiling systemic responses in kidney transplantation: interplay between the allograft transcriptome and serum proteins.Front Immunol. 2024 Jul 16;15:1398000. doi: 10.3389/fimmu.2024.1398000. eCollection 2024. Front Immunol. 2024. PMID: 39081308 Free PMC article.
-
Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing.Front Med (Lausanne). 2022 May 12;9:905464. doi: 10.3389/fmed.2022.905464. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35646951 Free PMC article.
References
-
- Abedini A, Zhu YO, Chatterjee S, Halasz G, Devalaraja-Narashimha K, Shrestha R, M SB, Park J, Zhou T, Ma Z, Sullivan KM, Hu H, Sheng X, Liu H, Wei Y, Boustany-Kari CM, Patel U, Almaani S, Palmer M, Townsend R, Blady S, Hogan J, Investigators TS, Morton L, Susztak K, Investigators TS, Urinary single-cell profiling captures the cellular diversity of the kidney. J Am Soc Nephrol. 2021;32:614–627. doi: 10.1681/ASN.2020050757. - DOI - PMC - PubMed
-
- Advani A, Huang Q, Thai K, Advani SL, White KE, Kelly DJ, Yuen DA, Connelly KA, Marsden PA, Gilbert RE. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism. Am J Pathol. 2011;178:2205–2214. doi: 10.1016/j.ajpath.2011.01.044. - DOI - PMC - PubMed
-
- Afshinnia F, Nair V, Lin J, Rajendiran TM, Soni T, Byun J, Sharma K, Fort PE, Gardner TW, Looker HC, Nelson RG, Brosius FC, Feldman EL, Michailidis G, Kretzler M, Pennathur S (2019) Increased lipogenesis and impaired beta-oxidation predict type 2 diabetic kidney disease progression in American Indians. JCI Insight 4 - PMC - PubMed
-
- Afshinnia F, Rajendiran TM, Karnovsky A, Soni T, Wang X, Xie D, Yang W, Shafi T, Weir MR, He J, Brecklin CS, Rhee EP, Schelling JR, Ojo A, Feldman H, Michailidis G, Pennathur S. Lipidomic signature of progression of chronic kidney disease in the chronic renal insufficiency cohort. Kidney Int Rep. 2016;1:256–268. doi: 10.1016/j.ekir.2016.08.007. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical